Not checked for notices yet.
Hepatic stellate cell reprogramming via exosome-mediated CRISPR/dCas9-VP64 delivery
Nianan Luo, Jiangbin Li, Yafeng Chen and 4 more
Drug Delivery · 2021
doi:10.1080/10717544.2020.1850917
Cited by papers we hold 3
- CRISPR/Cas9 therapeutics: progress and prospects · 2023No notice
- Exosomes, a New Star for Targeted Delivery · 2021No notice
- Development of Extracellular Vesicle Therapeutics: Challenges, Considerations, and Opportunities · 2021No notice
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.